A 29-year-old man in China, who started a fundraising campaign claiming that he needed money for cancer treatment, is accused ...

Dylan Horton was living his dream as a 23-year-old rookie defensive end for the Houston Texans when a call last October ...

CART-007, an anti-CD7 CAR T-cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia or T-cell lymphoblastic ...

A 29-year-old cancer patient in China has come under fire for allegedly misusing public donations intended for his medical treatment. The man, identified as Lan from Yichang City in Hubei province, ...

Survivorship: it’s a positive word that elicits the idea of success, winning and, as a four-time cancer survivor myself, the ...

Coulier revealed last week that he has been diagnosed with a "very aggressive" form of non-Hodgkin's lymphoma. He told PEOPLE ...

Selective Targeting and Reduction of CD19+ B Cells Observed with Each FT522 Dose in Study's First Low-dose Cohort without ...

Gabrielle Lowe, a local teen from Henderson, became a Formula 1 fan after watching last year’s Las Vegas Grand Prix. This year, thanks to the Make-A-Wish Southern Nevada, she will be attending the ...

Fate Therapeutics (NASDAQ:FATE) stock rallied 37% Monday after the company reported that the first patient in the Phase 1 ...

A widely used heart failure medication called sacubitril/valsartan was associated with a lower risk of heart damage compared ...

Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...